Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone Adjunct for Depression
NCT01109030Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Apr 2010; status: completed.
02
Drugs
pioglitazone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01109030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109030.